Daniel J. Sall
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Click Chemistry and Applications, Synthesis and Biological Activity, Synthesis and Characterization of Heterocyclic Compounds, Platelet Disorders and Treatments
Most-Cited Works
- → Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy(2012)192 cited
- → Dibasic Benzo[b]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding Orientation(1997)54 cited
- → Abstract 2819: Identification and characterization of a novel smoothened antagonist for the treatment of cancer with deregulated hedgehog signaling(2011)49 cited
- → Potent oxindole based human β3 adrenergic receptor agonists(2007)49 cited
- → Enantioselective total synthesis of 9S-dihydroerythronolide A seco acid(1989)45 cited
- → 1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors(2000)35 cited
- → Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[b]thiophenes(1999)35 cited
- → Synthesis and evaluation of 3-substituted analogs of 1,2,3,4-tetrahydroisoquinoline as inhibitors of phenylethanolamine N-methyltransferase(1988)33 cited
- → Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4-tetrahydroisoquinolines. Further studies on the hydrophilic pocket of the aromatic ring binding region of the active site(1987)32 cited
- → Chapter 11. Future Antithrombotic Therapy(1992)31 cited